• Tue news: Regeneron fails to block Eylea biosimilar. Inside the GLP-1 price war. Novartis inks $1B biobucks deal. UCB/Biogen lupus drug. Lilly Alzheimer’s drug approved in Japan. See more on our front page

Biogen Layoff Tracker

So can someone explain to me why we went through the bs of a review and my “merit increase” and all the generous “LTIs” when I’ve been shit canned and not getting any of it?
It was a joke, I agree. But not surprising. But honestly, I’ve never worked less. Especially since about last Thanksgiving. I knew the NCD would be brutal. Glad to be gone